Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiaprenorphine for relapse prevention after opioid detoxification
CTR20132666Phase 2Completed
- Sponsor
- Beijing Ziduhongye Technology Development
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tiaprenorphine in opioid use disorder (OUD), sponsored by Beijing Ziduhongye Technology Development. Started Dec 2014; status: completed.
02
Drugs
tiaprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on CTR20132666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132666.